Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Metropolitan Land Tbk. (MTLA) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Metropolitan Land Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Metropolitan Land Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Metropolitan Land Tbk. trades at Rp515 (market cap 3.94T, 20.7K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Metropolitan Land Tbk. is far larger — about 23.5× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (96.7K versus 20.7K). Which is the better fit depends on your goals.

MTLAOBAT
Market Cap
3.94T167.37B
Volume
20.7K96.7K
Lot
207967
Turnover
10.66M23.82M
Average Price
515.19246.34
Value
10.66M23.82M
Indicative Equilibrium Price
515248
Indicative Equilibrium Volume
541

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MTLA
View details
OBAT
View details

About Metropolitan Land Tbk.

PT Metropolitan Land Tbk (the Company) was established within the framework of the Domestic Capital Investment Law No. 6 year 1968 as amenden by Law No. 12 year 1970 based on notarial deed No. 37 dated February 16, 1994 of Endang Irawati Ekaputri, S.H., Notary in Jakarta.

Read more on MTLA

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT